SPL
STARPHARMA FPO [SPL]
Healthcare · ASX Small Cap
$0.4300 -6.5%
Updated 2026-03-02 · Scores refresh every scan
Appeared in 2 consecutive scans→ Score +6First seen: 2026-02-25
Score Breakdown
Technical43
Catalyst65
Sentiment50
Fundamental64
Momentum80
Risk Gate50
Active Signals
Bullish Signals
- Above 200-day MA (long-term uptrend)
- Strong cash runway (86 quarters)
- 4C filed 2026-01-28
- Moderate P/S ratio (13.3x)
- Strong revenue growth (+360%)
- EPS estimates revised downward (-10pts)
- Substantial holder(s) ceased (2)
- CANSLIM N: Near 52-week high (breakout territory)
- CANSLIM I: Institutional ownership (20%)
- Strong 12-1 momentum (+347%)
- Excellent risk-adjusted momentum (Sharpe 2.0)
- Strong revenue momentum (+360%)
- ASX200 bullish (+1.5% 5d)
- RBA cutting (+2pts)
- Trial readout: PHASE3 (est. 2012-07-20)
Risk Signals
- MACD momentum weakening
- Negative 5-day momentum (-6.5%)
- Deeply negative margins (-22%)
- Insufficient sentiment data (defaulting to neutral)
- Neutral/mixed sentiment
Recent Catalysts
NONE Half Yearly Report and Accounts
NONE Change in substantial holding
HIGH Ceasing to be a substantial holder
HIGH Ceasing to be a substantial holder
LOW Quarterly Activities/Appendix 4C Cash Flow Report
Recent ASX Announcements
| 2026-02-17 | Half Yearly Report and Accounts PRICE SENSITIVE |
| 2026-02-17 | Ceasing to be a substantial holder |
| 2026-02-10 | Ceasing to be a substantial holder |
| 2026-02-09 | Change in substantial holding |
| 2026-01-28 | Quarterly Activities/Appendix 4C Cash Flow Report PRICE SENSITIVE |
Key Metrics
$193.2M
Market Cap
1.8M
Avg Volume
0.7x
Vol Ratio
$0.08 — $0.53
52-Week Range
0.1%
Short Interest
20 qtrs
Cash Runway
-14.5%
ROE
-22.2%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | pass | Near 52w High |
| S | Supply & Demand | neutral | Float: 86% |
| L | Leader vs Laggard | pass | RS: 4 |
| I | Institutional Sponsorship | pass | Inst: 20% |
| M | Market Direction | pass | Bullish |
Sector: Healthcare
Ranked #10 of 119 · Sector avg: 51
View all Healthcare signals →